Oncogenesis (Jul 2024)

Involvement of Kindlin-1 in cutaneous squamous cell carcinoma

  • Giovana Carrasco,
  • Ifigeneia Stavrou,
  • Mairi Treanor-Taylor,
  • Henry Beetham,
  • Martin Lee,
  • Roza Masalmeh,
  • Artur Carreras-Soldevila,
  • David Hardman,
  • Miguel O. Bernabeu,
  • Alex von Kriegsheim,
  • Gareth J. Inman,
  • Adam Byron,
  • Valerie G. Brunton

DOI
https://doi.org/10.1038/s41389-024-00526-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Kindler syndrome (KS) is a rare genodermatosis resulting from loss-of-function mutations in FERMT1, the gene that encodes Kindlin-1. KS patients have a high propensity to develop aggressive and metastatic cutaneous squamous cell carcinoma (cSCC). Here we show in non-KS-associated patients that elevation of FERMT1 expression is increased in actinic keratoses compared to normal skin, with a further increase in cSCC supporting a pro-tumorigenic role in this population. In contrast, we show that loss of Kindlin-1 leads to increased SCC tumor growth in vivo and in 3D spheroids, which was associated with the development of a hypoxic tumor environment and increased glycolysis. The metalloproteinase Mmp13 was upregulated in Kindlin-1-depleted tumors, and increased expression of MMP13 was responsible for driving increased invasion of the Kindlin-1-depleted SCC cells. These results provide evidence that Kindlin-1 loss in SCC can promote invasion through the upregulation of MMP13, and offer novel insights into how Kindlin-1 loss leads to the development of a hypoxic environment that is permissive for tumor growth.